Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Takako Matsuoka"'
Autor:
Shunsuke Mori, Yukinori Koga, Kazuyoshi Nakamura, Sayuri Hirooka, Takako Matsuoka, Hideshi Uramoto, Osamu Sakamoto, Yukitaka Ueki
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243110 (2020)
ObjectiveThe aim of this study was to compare long-term mortality following diagnosis of pulmonary nontuberculous mycobacterial (NTM) disease between patients with and without rheumatoid arthritis (RA) and to evaluate predictive factors for death out
Externí odkaz:
https://doaj.org/article/0cfe863fc98d4042b5169f4ff41e66bc
Autor:
Sachiko Miyake, Sangwan Kim, Wataru Suda, Kenshiro Oshima, Masakazu Nakamura, Takako Matsuoka, Norio Chihara, Atsuko Tomita, Wakiro Sato, Seok-Won Kim, Hidetoshi Morita, Masahira Hattori, Takashi Yamamura
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137429 (2015)
The pathogenesis of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, remains poorly understood. Patients with MS typically present with recurrent episodes of neurological dysfunctions such as blindness, paresis, and
Externí odkaz:
https://doaj.org/article/8b98f892acb44f699cff1deb0395c8a5
Autor:
Norio Chihara, Toshimasa Aranami, Shinji Oki, Takako Matsuoka, Masakazu Nakamura, Hitaru Kishida, Kazumasa Yokoyama, Yoshiyuki Kuroiwa, Nobutaka Hattori, Tomoko Okamoto, Miho Murata, Tatsushi Toda, Sachiko Miyake, Takashi Yamamura
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83036 (2013)
Neuromyelitis optica (NMO) is an inflammatory disease characterized by recurrent attacks of optic neuritis and myelitis. It is generally accepted that autoantibodies against aquaporin 4 water channel protein play a pathogenic role in neuromyelitis op
Externí odkaz:
https://doaj.org/article/a39af705e12b4dca8b6e48942b5c4d4a
Autor:
Takako Matsuoka, Manabu Araki, Youwei Lin, Tomoko Okamoto, Gold, Ralf, Norio Chihara, Wakiro Sato, Atsuko Kimura, Hisateru Tachimori, Katsuichi Miyamoto, Susumu Kusunoki, Takashi Yamamura
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation; Jan2024, Vol. 11 Issue 1, p1-12, 12p
Autor:
Takako, Matsuoka, Aoi, Miyazaki, Sachiyo, Kosai, Kazuyoshi, Nakamura, Hideshi, Uramoto, Hironori, Kobayashi, Osamu, Sakamoto
Publikováno v:
Internal Medicine.
A 77-year-old man was referred to our hospital for abnormal thoracic radiographs. Computed tomography (CT) revealed a 20-mm subpleural ground-glass opacity in the right S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c56a7c3a2c489f8baf91ae41ef92c7b2
https://doi.org/10.2169/internalmedicine.0112-22
https://doi.org/10.2169/internalmedicine.0112-22
Autor:
Sayuri Hirooka, Osamu Sakamoto, Kazuyoshi Nakamura, Yosuke Kakiuchi, Takako Matsuoka, Hideshi Uramoto, Takaaki Ito
Publikováno v:
Haigan. 61:130-137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5ad4a4ff2a90d44ecb48fe66a67a0cb
https://doi.org/10.2482/haigan.61.130
https://doi.org/10.2482/haigan.61.130
Autor:
Kuniko Kohyama, Taiki Shima, Akihisa Okumura, Tomonori Suzuki, Takako Matsuoka, Toshiaki Shimizu, Hiroshi Sakuma, Masaharu Hayashi
Publikováno v:
Epilepsy & Seizure. 10:22-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::909d50fea960ec838b7d5117131e72a8
https://doi.org/10.3805/eands.10.22
https://doi.org/10.3805/eands.10.22
Autor:
Toshimasa Aranami, Sachiko Miyake, Miho Murata, Tomoko Okamoto, Manabu Araki, Susumu Kusunoki, Takako Matsuoka, Takashi Yamamura, Katsuichi Miyamoto
Publikováno v:
Neurology. 82:1302-1306
To evaluate the safety and efficacy of a humanized anti-interleukin-6 receptor antibody, tocilizumab (TCZ), in patients with neuromyelitis optica (NMO).Seven patients with anti-aquaporin-4 antibody (AQP4-Ab)-positive NMO or NMO spectrum disorders wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859b1f6c3842075a98033c4a7ef3601f
https://doi.org/10.1212/wnl.0000000000000317
https://doi.org/10.1212/wnl.0000000000000317
Autor:
Masakazu Nakamura, Toshimasa Aranami, Norio Chihara, Miho Murata, Wakiro Sato, Manabu Araki, Sachiko Miyake, Youwei Lin, Takako Matsuoka, Takashi Yamamura, Masafumi Ogawa, Tomoko Okamoto
Publikováno v:
Multiple Sclerosis Journal. 20:1371-1380
Background: Fingolimod is an oral drug approved for multiple sclerosis (MS) with an ability to trap central memory T cells in secondary lymphoid tissues; however, its variable effectiveness in individual patients indicates the need to evaluate its ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5e0157004ae1529b3256554428dd05
https://doi.org/10.1177/1352458514523496
https://doi.org/10.1177/1352458514523496
Publikováno v:
Haigan. 53:882-887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67494208c7e4101ee38b1911a9badfd5
https://doi.org/10.2482/haigan.53.882
https://doi.org/10.2482/haigan.53.882